Insider Transactions in Q2 2021 at Schrodinger, Inc. (SDGR)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,609
-0.28%
|
$2,782,284
$76.45 P/Share
|
|
Jun 29
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
28,708
-0.15%
|
$2,239,224
$78.53 P/Share
|
|
Jun 28
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
56,034
-0.28%
|
$4,426,686
$79.04 P/Share
|
|
Jun 25
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
220,394
-0.81%
|
$17,190,732
$78.31 P/Share
|
|
Jun 24
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
78,633
-0.57%
|
$6,133,374
$78.22 P/Share
|
|
Jun 23
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
53,946
-0.39%
|
$4,153,842
$77.06 P/Share
|
|
Jun 22
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
129,002
-0.45%
|
$9,804,152
$76.09 P/Share
|
|
Jun 21
2021
|
Robert Lorne Abel Officer |
SELL
Open market or private sale
|
Direct |
15,602
-100.0%
|
$1,154,548
$74.16 P/Share
|
|
Jun 21
2021
|
Robert Lorne Abel Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,602
+30.61%
|
$124,816
$8.09 P/Share
|
|
Jun 21
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
60,449
-0.17%
|
$4,473,226
$74.32 P/Share
|
|
Jun 18
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
52,784
-0.24%
|
$3,906,016
$74.75 P/Share
|
|
Jun 17
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
51,945
-0.18%
|
$3,895,875
$75.37 P/Share
|
|
Jun 16
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,195
-0.17%
|
$2,752,430
$74.29 P/Share
|
|
Jun 15
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
60,414
-0.2%
|
$4,470,636
$74.54 P/Share
|
|
Jun 14
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
43,463
-0.19%
|
$3,346,651
$77.52 P/Share
|
|
Jun 14
2021
|
Joel Lebowitz EVP & CFO |
SELL
Open market or private sale
|
Direct |
5,574
-77.27%
|
$429,198
$77.65 P/Share
|
|
Jun 14
2021
|
Joel Lebowitz EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,574
+50.0%
|
$22,296
$4.34 P/Share
|
|
Jun 08
2021
|
Karen Akinsanya President of R&D, Therapeutics |
SELL
Open market or private sale
|
Direct |
10,242
-96.09%
|
$768,150
$75.79 P/Share
|
|
Jun 08
2021
|
Karen Akinsanya President of R&D, Therapeutics |
BUY
Exercise of conversion of derivative security
|
Direct |
10,242
+50.0%
|
$40,968
$4.34 P/Share
|
|
Jun 07
2021
|
Karen Akinsanya President of R&D, Therapeutics |
SELL
Open market or private sale
|
Direct |
6,479
-100.0%
|
$485,925
$75.1 P/Share
|
|
Jun 07
2021
|
Karen Akinsanya President of R&D, Therapeutics |
BUY
Exercise of conversion of derivative security
|
Direct |
6,479
+50.0%
|
$25,916
$4.34 P/Share
|
|
Jun 07
2021
|
Rosana Kapeller Libermann Director |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$75,000
$75.0 P/Share
|
|
Jun 07
2021
|
Rosana Kapeller Libermann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$4,000
$4.34 P/Share
|
|
May 26
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
980
-0.01%
|
$67,620
$69.09 P/Share
|
|
May 25
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
45,482
-0.2%
|
$3,047,294
$67.95 P/Share
|
|
May 24
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
27,594
-0.12%
|
$1,793,610
$65.18 P/Share
|
|
May 20
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,000
-0.11%
|
$1,600,000
$64.03 P/Share
|
|
May 19
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,000
-0.11%
|
$1,550,000
$62.75 P/Share
|
|
May 18
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
28,402
-0.09%
|
$1,789,326
$63.51 P/Share
|
|
May 18
2021
|
Joel Lebowitz EVP & CFO |
SELL
Open market or private sale
|
Direct |
5,574
-100.0%
|
$356,736
$64.45 P/Share
|
|
May 18
2021
|
Joel Lebowitz EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,574
+50.0%
|
$22,296
$4.34 P/Share
|
|
May 14
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,000
-0.08%
|
$1,475,000
$59.88 P/Share
|
|
May 13
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,000
-0.07%
|
$1,475,000
$59.99 P/Share
|
|
May 12
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
25,000
-0.08%
|
$1,500,000
$60.94 P/Share
|
|
May 07
2021
|
Kenneth Patrick Lorton EVP, CTO & COO, Software |
SELL
Bona fide gift
|
Direct |
6,500
-11.67%
|
-
|
|
May 07
2021
|
Kenneth Patrick Lorton EVP, CTO & COO, Software |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+1.77%
|
$20,000
$10.67 P/Share
|
|
May 06
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,000
-0.1%
|
$2,010,000
$67.46 P/Share
|
|
May 05
2021
|
Robert Lorne Abel Officer |
SELL
Open market or private sale
|
Direct |
15,873
-76.8%
|
$1,095,237
$69.99 P/Share
|
|
May 05
2021
|
Robert Lorne Abel Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,873
+31.79%
|
$15,873
$1.57 P/Share
|
|
May 05
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,000
-0.1%
|
$2,100,000
$70.03 P/Share
|
|
May 04
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,000
-0.08%
|
$2,100,000
$70.78 P/Share
|
|
Apr 29
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,400
-0.08%
|
$2,280,000
$75.93 P/Share
|
|
Apr 28
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,000
-0.15%
|
$2,660,000
$76.4 P/Share
|
|
Apr 27
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
36,125
-0.15%
|
$2,781,625
$77.95 P/Share
|
|
Apr 21
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,000
-0.1%
|
$2,100,000
$70.99 P/Share
|
|
Apr 20
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,000
-0.09%
|
$2,130,000
$71.22 P/Share
|
|
Apr 19
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
30,000
-0.08%
|
$2,220,000
$74.96 P/Share
|
|
Apr 15
2021
|
David E Shaw > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
45,000
-0.28%
|
$3,510,000
$78.22 P/Share
|
|
Apr 14
2021
|
Joel Lebowitz EVP & CFO |
SELL
Open market or private sale
|
Direct |
5,574
-68.59%
|
$434,772
$78.5 P/Share
|
|
Apr 14
2021
|
Joel Lebowitz EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,574
+50.0%
|
$22,296
$4.34 P/Share
|